- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05346913
ICBT Program for Caregivers of Persons With SCI
March 13, 2024 updated by: Swati Mehta, Lawson Health Research Institute
Internet-Delivered Cognitive Behaviour Therapy Program for Caregivers of Persons With Spinal Cord Injury: A Pilot Study
Spinal cord injuries have a devastating effect on individuals incurring the life changing event; however, the injury can also affect those who are integrally involved in their care.
Assisting individuals after an SCI frequently falls on unpaid, family caregivers.
Studies have reported that caregivers experienced significantly greater negative outcomes than positives.
The most common negative outcome factors were high levels of burden, poor adjustment to role, decreased QOL, emotional distress, and strain on relationships.
Burden of care was also associated with lower levels of functioning of the care recipient, demonstrating the integral relationship between those who provide care and those who receive it.
Considering their importance in maintaining their care recipient's wellbeing post-injury, caregivers require ongoing support as a central part of the wider healthcare system.
Numerous caregivers are unprepared to handle the responsibilities of their role and lack specialized training to efficiently cope with the burden.
Guided internet-delivered CBT (ICBT) offers an accessible and flexible approach for psychosocial service delivery in the community.
Evidence for the effectiveness of ICBT has been reported in various populations.
The results from our study provide evidence for the potential of guided ICBT to improve psychosocial outcomes among those with SCI.
Enhancing the overall wellbeing of the caregiver has previously been shown to improve outcomes of those with SCI.
However, evidence for the acceptability and effectiveness of an ICBT approach among caregivers is lacking; as a first step, we plan to conduct a feasibility study of ICBT for SCI caregivers.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Swati Mehta, PhD
- Phone Number: 42359 519-685-8500
- Email: swati.mehta@sjhc.london.on.ca
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- adults ≥ 18 years
- have provided care to a person with SCI in the community for a period of over six months post injury
- report elevated symptoms of anxiety and/or depression
- access to a computer and the internet
- cognitive capacity to read and understand the content of the intervention.
Exclusion Criteria:
- high risk of suicide
- primary problems with psychosis, alcohol or drug problems, mania
- currently receiving active psychological treatment for anxiety or depression
- concerns about online therapy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Caregivers of Persons with Spinal Cord Injury (mTBI)
|
ICBT provides online structured self-help modules over several months based on the principles of CBT in combination with weekly guidance through emails and telephone calls.
The course comprises 6 online lessons that provide psychoeducation about: 1) symptom identification and the cognitive behavioural model; 2) thought monitoring and challenging; 3) de-arousal strategies and pleasant activity scheduling; 4) graduated exposure/pacing; 5) memory and attention; and 6) relapse prevention.
Participants will also have the opportunity to ask any questions regarding the content of the program materials and will receive a response from their Guide within 48-72 hours.
Guide will spend ~15 mins.
per week/per participant.
All Guides have completed a university program (psychology or social work) and are registered clinicians or students working under supervision of a registered clinician.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Depression
Time Frame: Time Frame: Baseline to 3 months
|
Patient Health Questionnaire - 9 Item (PHQ-9).
Higher total scores indicate greater severity of depression.
Scores range from 0 to 27.
|
Time Frame: Baseline to 3 months
|
|
Change in Caregiver Burden
Time Frame: Time Frame: Baseline to 3 months
|
Craig Caregiver Assessment of Reward and Effort.
Higher scores indicate greater caregiver.
Scores range from 0 to 96.
|
Time Frame: Baseline to 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Anxiety
Time Frame: Time Frame: Baseline to 3 months
|
Generalize Anxiety Disorder - 7 Item (GAD7).
Higher total scores indicate greater severity of anxiety.
Scores range from 0 to 21.
|
Time Frame: Baseline to 3 months
|
|
Change in quality of life
Time Frame: Time Frame: Baseline to 3 months
|
The Visual Analogue Scale of the EuroQol five-dimension (EQ-5D) questionnaire will be used.
Higher numbers indicates poorer quality of life.
Scores range from 0 to 100
|
Time Frame: Baseline to 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Swati Mehta, PhD, Lawson Health Research Institute
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
April 1, 2024
Primary Completion (Estimated)
September 1, 2024
Study Completion (Estimated)
September 1, 2024
Study Registration Dates
First Submitted
April 21, 2022
First Submitted That Met QC Criteria
April 21, 2022
First Posted (Actual)
April 26, 2022
Study Record Updates
Last Update Posted (Actual)
March 15, 2024
Last Update Submitted That Met QC Criteria
March 13, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 118285P2
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
Clinical Trials on Internet-delivered Cognitive Behavioural Therapy(ICBT)
-
National University of SingaporeAgency for Integrated Care, Singapore; MOH Office for Healthcare Transformation...Not yet recruitingCognitive Behavioral Therapy | Depression and/or Anxiety in the Mild-to-moderate RangeSingapore
-
Lawson Health Research InstituteRecruitingDepression | Anxiety | Mild Traumatic Brain Injury | Internet-Delivered Cognitive Behavioural TherapyCanada
-
Institute of Mental Health, SingaporeRecruitingDepression | Anxiety DisordersSingapore
-
Memorial University of NewfoundlandCompletedChronic Pain | Major Depressive DisorderCanada
-
Karolinska InstitutetRegion StockholmActive, not recruiting
-
Centre for Addiction and Mental HealthCompletedGeneralized Anxiety Disorder | Major Depressive Disorder | Social Anxiety Disorder | Panic DisorderCanada
-
Stockholm UniversityCompletedProcrastinationSweden
-
Karolinska InstitutetCompletedObsessive-Compulsive DisorderSweden
-
Philipps University Marburg Medical CenterLinkoeping UniversityCompleted
-
Karolinska InstitutetRegion StockholmCompleted